8-K
filed September 2, 2022, 7:59 PM ET
ticker VANI
CIK 0001266806
M&A
confidence high
sentiment neutral
materiality 0.85
Vivani (fka Second Sight) completes merger with Nano Precision Medical; ticker changes to VANI
Vivani Medical, Inc.
- Closed merger with NPM on Aug 30, 2022; issued 37.6M shares to NPM holders, giving them ~74.1% ownership.
- Name changed to Vivani Medical; common stock begins trading under VANI; warrants VANIW to be delisted.
- Board reduced to five; Adam Mendelsohn appointed CEO; new C-suite includes Brigid Makes (CFO), Truc Le (COO).
- Pro forma cash ~$55M; lead drug implant NPM-119 for Type 2 diabetes expected to begin clinical evaluation by end of 2022.
- NPM's unaudited H1 2022 net loss $8.0M on zero revenue; cash and equivalents $3.45M as of June 30, 2022.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Lisa Porter was appointed as Chief Medical Officer at Vivani Medical, Inc..
- Action
- appointed
- Role
- Chief Medical Officer
Exact text from the filing
As of the Effective Time, the Board appointed Adam Mendelsohn, as Chief Executive Officer of the Company, Brigid A. Makes, as Chief Financial Officer of the Company, Truc Le, as Chief Operating Officer of the Company, Donald Dwyer, as Chief Business Officer of the Company, and Lisa Porter, as Chief Medical Officer of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Adam Mendelsohn was appointed as Director at Vivani Medical, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
On and as of the Effective Date, the Board appointed Adam Mendelsohn as a director of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Scott Dunbar resigned as Acting Chief Executive Officer at Vivani Medical, Inc..
- Action
- resigned
- Role
- Acting Chief Executive Officer
Exact text from the filing
Scott Dunbar, Company’s Acting Chief Executive Officer and Edward Sedo, the Company’s Acting Chief Accounting Officer, resigned as officers of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Donald Dwyer was appointed as Chief Business Officer at Vivani Medical, Inc..
- Action
- appointed
- Role
- Chief Business Officer
Exact text from the filing
As of the Effective Time, the Board appointed Adam Mendelsohn, as Chief Executive Officer of the Company, Brigid A. Makes, as Chief Financial Officer of the Company, Truc Le, as Chief Operating Officer of the Company, Donald Dwyer, as Chief Business Officer of the Company, and Lisa Porter, as Chief Medical Officer of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Matthew Pfeffer resigned as Director at Vivani Medical, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
Pursuant to the Merger Agreement, immediately prior to and effective upon the Merger, Jonathan Will McGuire and Matthew Pfeffer, resigned from the Board and any respective committees of the Board to which they belonged, which resignations were not the result of any disagreements with the Company relating to the Company’s operations, policies or practices .
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Edward Sedo resigned as Acting Chief Accounting Officer at Vivani Medical, Inc..
- Action
- resigned
- Role
- Acting Chief Accounting Officer
Exact text from the filing
Scott Dunbar, Company’s Acting Chief Executive Officer and Edward Sedo, the Company’s Acting Chief Accounting Officer, resigned as officers of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Truc Le was appointed as Chief Operating Officer at Vivani Medical, Inc..
- Action
- appointed
- Role
- Chief Operating Officer
Exact text from the filing
As of the Effective Time, the Board appointed Adam Mendelsohn, as Chief Executive Officer of the Company, Brigid A. Makes, as Chief Financial Officer of the Company, Truc Le, as Chief Operating Officer of the Company, Donald Dwyer, as Chief Business Officer of the Company, and Lisa Porter, as Chief Medical Officer of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Brigid A. Makes was appointed as Chief Financial Officer at Vivani Medical, Inc..
- Action
- appointed
- Role
- Chief Financial Officer
Exact text from the filing
As of the Effective Time, the Board appointed Adam Mendelsohn, as Chief Executive Officer of the Company, Brigid A. Makes, as Chief Financial Officer of the Company, Truc Le, as Chief Operating Officer of the Company, Donald Dwyer, as Chief Business Officer of the Company, and Lisa Porter, as Chief Medical Officer of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Jonathan Will McGuire resigned as Director at Vivani Medical, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
Pursuant to the Merger Agreement, immediately prior to and effective upon the Merger, Jonathan Will McGuire and Matthew Pfeffer, resigned from the Board and any respective committees of the Board to which they belonged, which resignations were not the result of any disagreements with the Company relating to the Company’s operations, policies or practices .
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Adam Mendelsohn was appointed as Chief Executive Officer at Vivani Medical, Inc..
- Action
- appointed
- Role
- Chief Executive Officer
Exact text from the filing
As of the Effective Time, the Board appointed Adam Mendelsohn, as Chief Executive Officer of the Company, Brigid A. Makes, as Chief Financial Officer of the Company, Truc Le, as Chief Operating Officer of the Company, Donald Dwyer, as Chief Business Officer of the Company, and Lisa Porter, as Chief Medical Officer of the Company.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.